Mina L Xu
@MinaXu7
Followers
1K
Following
2K
Media
68
Statuses
562
Physician, Professor of Pathology at Yale University School of Medicine, Director of Hematopathology, (tweets/retweets are not medical advice)
Yale University
Joined March 2016
We’ve reached over 750 voices in the 2025 Global FL Patient Survey! 💜 Every voice helps build a clearer picture of life with follicular lymphoma and shapes the future of care. Help us reach 1,000 by 19 October 🌍 👉 https://t.co/pQ4ZPsVqsB
#FollicularLymphoma #PatientVoice
1
2
9
Join us for the 2nd Yale Center for Research on Aging (Y-Age) Symposium this Monday, October 13 at the Anlyan Center Auditorium at @YaleMed. It's a day-long discussion on human longevity, geroscience, and the biology of #aging. https://t.co/EbPTo6CZ67
0
2
5
T cells to the rescue (again)!! Congratulations to the winners! Quite frankly I would have added S. Rudensky…
BREAKING NEWS The 2025 #NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”
9
36
291
A very exciting era for our patients with #AMLsm
Congratulations to @Dr_AmerZeidan and our #Leukemia Clinical Research Team for enrolling the 1st patient in the #KOMET017 global Phase 3 study for acute myeloid leukemia #AML! https://t.co/3UNQHBIe9g
@SmilowCancer @YaleHemOnc @yalediscovers
6
5
84
🚨New Pre-Print Alert! 🚨 Happy to share our latest work on human bone marrow imaging using multiplex IF! #mdssm Single-cell spatial mapping reveals dynamic bone marrow microarchitectural alterations and enhances clinical diagnostics in MDS | bioRxiv
biorxiv.org
Myelodysplastic neoplasms (MDS) are genetically diverse hematopoietic cancers characterized by ineffective blood cell production, peripheral cytopenias, and an increased risk of acute myeloid...
5
10
32
Study, whose authors include @VishwaDeepDixi1 of @YalePathology & @YaleMed, finds that certain immune cells that regulate fat metabolism & control age-related inflammation decline during #aging. https://t.co/mbUY0UsPTu
0
5
15
Can’t believe our amazing oncology nurse practitioner Erin Medoff is retiring! She has saved so many lives over the decades & taught me and countless others thru her wisdom and intuitive care for our cancer patients @Dr_AmerZeidan @YaleCancer
0
3
28
Many thanks to @PengJi_Lab of @NUFeinbergMed for presenting today’s #Pathology Grand Rounds on “The Role of Inflammation in the Evolution from Clonal Hematopoiesis to MDS & AML” Here’s Dr. Ji, center, w/hosts, @gcai1978, left, & @MinaXu7, both Professors of Pathology @YaleMed
0
2
17
Butterfly in the sky; I can go twice as high...what is the translocation? #Hemepath On a busy clinical service, I got a funny shoutout from unknown hospital staff while doing my usual speed walk across buildings: "Slow down young lady! Or you're going to get a speeding ticket!"
1
6
25
Congratulations, my friend Carlos @CattoMurga on this new study to further characterize the elusive effusion based lymphoma. Always a joy to work with you! https://t.co/9R2Hc8H9Xm Thanks to @Savanaplastic for the support. @MDPIOpenAccess #HemePath #lymsm
mdpi.com
Background: Effusion-based lymphoma (EBL) is a rare and aggressive large B-cell lymphoma. It presents as a body cavity effusion without a solid mass, lacks HHV-8 association, and typically expresses...
0
3
15
How can molecular testing be better integrated into AML care? In Episode 1 of The AML Expert Series, hear practical strategies to overcome barriers & apply testing insights to optimize patient outcomes. AML Expert Series, Ep 1 – Tune in now! https://t.co/GWWHmu04Of
#AML #meded
0
4
7
#ASH #ASH25 #ASH2025 #ASHScientificCommittee hard at work past week, few not present due to global time zones; honored to work with colleagues #ASH26 #hematopathology #heme #hemepath #path #lab #clinicallaboratoryhematology
0
1
12
1 Acute myeloid leukemia (AML), blast morphology often provides important clues to the underlying genetics
12
80
253
🚨Watch our Post-#EHA 2025 #MDS Highlights for expert insights into novel therapies, transplant strategies and #AI-guided diagnostics in #MDS 🩸 🎥 We cover: ✅ Updates with #hypomethylating agents and combination strategies in #MDS, MML, and #VEXASsyndrome ✅ Exploring
0
4
9
Northern lights apparently visible in CT last night! Photo by Braden Lynn from Mansfield Hollow Dam (I love auroras but am not motivated enough at 2 am):
0
1
18
My first 5K…Haven’t run outside in 6 months but finished within top 12th of women, all ages. Thank you to @archie_enninful for bullying me into this. So awesome to run with Fan Lab @RongFan8 ! I will train next time.
3
2
32
A @ysphbiostat study led by @JeffTownsend reveals #tobacco alters lung #adenocarcinoma evolution: smokers’ tumors favor KRAS/KEAP1/STK11, never-smokers’ favor EGFR/PIK3CA—revealing distinct treatment vulnerabilities. https://t.co/0JySFr7oJ7
@SmilowCancer @TooMuchVitaminK
biorxiv.org
Background Tobacco smoke is a known mutagen. However, its physiological effects on the lung may also influence the somatic selective pressures acting on mutations, further shaping cancer evolution....
0
3
3
Happy to share our episode presented by me and Dr Usmani on “HemeTalks: Conversations in Hematology Education'' on management of relapse myeloma. Listen along here:
0
4
18
Are you up to date on the latest #hematology treatment strategies?🩸Learn from experts like @Dr_AmerZeidan & @DrCCutler and earn up to 3 free CE/CME credits on-demand! Access Courses Here: https://t.co/FjlFWFB1R5
https://t.co/Rcq6j00HD7
https://t.co/gPhnFZIqzy
#oncology #CME
0
2
5